The modest changes in signaling compared to controls is congruent with previous studies which demonstrated only modest changes in the steady-state levels of PI3K signaling in breast cancer cells with PIK3CA mutations (Stemke-Hale et al., 2008). The gene discussed is PIK3CA; the disease is breast cancer.